Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Noveome Biotherapeutics Inc patents


Recent patent applications related to Noveome Biotherapeutics Inc. Noveome Biotherapeutics Inc is listed as an Agent/Assignee. Note: Noveome Biotherapeutics Inc may have other listings under different names/spellings. We're not affiliated with Noveome Biotherapeutics Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "N" | Noveome Biotherapeutics Inc-related inventors


Methods for treating nervous system injury and disease

The invention is directed to methods for treating nervous system injury and disease, in particular traumatic brain injury and degenerative nervous system disease. Such methods utilize novel compositions, including but not limited to trophic factor-secreting extraembryonic cells (herein referred to as tse cells), including, but not limited to, amnion-derived multipotent progenitor cells (herein referred to as amp cells) and conditioned media derived therefrom (herein referred to as amnion-derived cellular cytokine solution or accs), each alone or in combination with each other and/or other agents.. ... Noveome Biotherapeutics Inc

Treatment of diseases and conditions caused by increased vascular permeability

The invention is directed to methods for the treatment of diseases and conditions caused by increased vascular permeability. The invention is also directed to methods for returning vascular permeability that is a symptom of a disease or condition to a homeostatic state. ... Noveome Biotherapeutics Inc

Methods for treating ocular contusion and blunt injury and traumatic injury of the optic nerve

The invention is directed to methods for treating ocular contusion and blunt injury to the eye and for treating traumatic injury of the optic nerve. The invention is further directed to treating ocular contusion and blunt injury to the eye and for treating traumatic injury of the optic nerve by administering to a subject suffering from such conditions amnion-derived cellular cytokine solution (accs), including novel immediate-release, targeted-release, and sustained-release (sr) accs compositions (referred to herein as “sr-accs” compositions) and/or and amnion-derived multipotent progenitor (amp) cell compositions. ... Noveome Biotherapeutics Inc

Methods for preventing or treating optic neuritis

The invention is directed to methods for preventing and/or treating optic neuritis. The invention is further directed to reducing inflammation associated with the development of optic neuritis. ... Noveome Biotherapeutics Inc

Methods for preventing and/or treating nasal polyps and rhinosinusitis

The invention is directed to methods for preventing and/or treating nasal polyps. The invention is further directed to methods for preventing and/or treating rhinosinusitus. ... Noveome Biotherapeutics Inc

Novel cell-derived composition

The invention is directed to a novel cell-derived composition having bone growth, regeneration, and repair promoting properties. In particular, the invention is directed to a novel cell-derived composition having bone growth, regeneration, and repair promoting properties termed amnion-derived cellular cytokine solution-b (accs-b). ... Noveome Biotherapeutics Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Noveome Biotherapeutics Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Noveome Biotherapeutics Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###